New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Lee accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, University of Medicine and Dentistry of New Jersey
Radiation Oncology - Columbia Presbyterian Medical Center
I am a radiation oncologist with more than 17 years of experience. I specialize in using advanced forms of radiation to treat head and neck cancer, including thyroid cancer. These include proton therapy, intensity modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiation therapy. My goal in using these technologies is to improve my patients’ outcomes while decreasing potential treatment side effects and preserving their quality of life. No matter which treatment option we use, I care for all of my patients as if they were part of my family. This means creating a plan tailored to their unique disease, and doing everything I can to help them get well.
There are many effective treatment options for people diagnosed with tumors in the head and neck. We can get rid of many of these tumors without the need for an invasive surgery. Instead, we can use radiation therapy alone or in combination with immunotherapy, targeted therapy, or chemotherapy. This is especially true for tumors in the tonsils, base of the tongue, and soft palate.
People who come to me for their care never see only me. I believe it’s important to consult with my colleagues in medical oncology and surgery. All of my patients benefit from the combined expertise of several doctors who are committed to curing their cancer and helping them get back to their lives.
My research is focused on ways to make radiation therapy for head and neck cancers safer and more effective. I am the principal investigator for many national and international clinical trials. For example, for people with very advanced head and neck cancer, I am researching the effectiveness of immunotherapy combined with chemoradiation. I am also studying the use of plasma Epstein-Barr virus DNA to individualize treatment for people with nasopharyngeal cancer.
In recent years, we have seen a rise in cases of head and neck cancer caused by the human papilloma virus (HPV). Though these cancers may respond to conventional therapies, we need to find innovative new ways to treat them. I am one of the leading experts in this area. I am currently leading a trial to evaluate the use of smaller radiation doses for select people with HPV-related head and neck cancers. These smaller doses mean we can help people avoid possible side effects from extensive radiation.
I am also very active in many cooperative groups such as NRG Oncology and National Cancer Institute committees. I have authored numerous articles focusing on head and neck cancers with the goal of defining appropriate treatment for people with these diseases. I am one of the major thought leaders in the world for the treatment of head and neck cancer.
People who are diagnosed with cancer may feel hopeless. When I meet with patients, I always try to restore their hope by clearly explaining treatment options, answering questions, and discussing any concerns. I also remind them that even though we will work to make their tumor go away, I won’t be going anywhere; I will be with them every step of the way and will continue to see them for the rest of their lives.
All of my patients benefit from the combined expertise of several doctors who are committed to curing their cancer and helping them get back to their lives.
Awards and Honors
- Castle Connolly: New York Magazine Top Doctors (2013-2020)
MSK Ranked #1 Center for Ear, Nose, and Throat Care
- Clinical Trials Investigated by Dr. Lee
- A Phase II Study of Proton Re-Irradiation Therapy for Recurrent Head and Neck Cancer
- A Phase II Study of Proton versus Photon Beam Radiotherapy to Treat Head and Neck Cancer
- A Phase II/III Study Comparing Proton Radiation Therapy with Photon Radiation Therapy in People with Oropharyngeal Cancer of the Head and Neck
- A Phase II/III Study of Surgery Followed by Radiation Therapy plus either Cisplatin, Docetaxel, or Both Drugs for High-Risk Squamous Cell Cancer of the Head and Neck
- A Study Assessing a Major Dose Reduction in Radiation Therapy for HPV-Positive Oropharyngeal Cancer
- A Study of Customized Treatment for Nasopharyngeal Cancer Based on Epstein-Barr Virus DNA
- Clinical Trials Co-Investigated by Dr. Lee
- A Phase I/II Study of [225Ac]-FPI-1434 in People with Advanced or Metastatic Solid Tumors
- A Phase III Study of Pembrolizumab Immunotherapy Before Surgery and in Combination with Standard Therapy After Surgery for Stage III-IVA Head and Neck Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Lee’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Nancy Y. Lee discloses the following relationships and financial interests:
Provision of Services
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.